Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms |
Target |
Mechanism AR degraders(Androgen Receptor degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC57H61N7O7S |
InChIKeyVPTPISILDHXZGQ-NXPDQULFSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Preclinical | JP | 23 Jun 2017 | |
Prostatic Cancer | Preclinical | JP | 23 Jun 2017 |